Editorial Board — Medscape Psychiatry & Mental Health

Board Members

  • Scott H. Kollins, PhD
    • Duke University Medical Center
      Durham, North Carolina
  • Jeffrey A. Lieberman, MD
    • Columbia University
      New York-Presbyterian Hospital/Columbia University Medical Center
      New York, New York
  • Jon McClellan, MD
    • University of Washington
      Seattle, Washington
      Child Study and Treatment Center
      Lakewood, Washington
  • Drew Ramsey, MD
    • Columbia University
      New York, New York
  • Stephen M. Strakowski, MD
    • Professor of Psychiatry and Behavioral Neuroscience
      Psychology, and Biomedical Engineering,
      University of Cincinnati College of Medicine
 

Board Member Details

Christoph U. Correll, MD
Christoph U. Correll, MD

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital, Glen Oaks, New York

Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as consultant and/or advisor to or has received honoraria from: Alkermes, Inc; Allergan; Bristol-Myers Squibb; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; LB Pharma; Lundbeck, Inc; Medavante; Medscape; Neurocrine; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc; Sunovion; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Lundbeck, Inc; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc; Sunovion; Takeda Pharmaceuticals North America, Inc.
Received a research grant from: Takeda Pharmaceuticals North America, Inc
Received income in an amount equal to or greater than $250 from: Alkermes, Inc; Allergan; Bristol-Myers Squibb; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; LB Pharma; Lundbeck, Inc; Medavante; Medscape; Neurocrine; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc; Sunovion; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Provided expert testimony for: Bristol-Myers Squibb Company; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.
Served on Data Safety Monitoring Board for: Lundbeck, Inc; Pfizer Inc
Received grant support from: Takeda Pharmaceuticals North America, Inc

Emily Deans, MD
Emily Deans, MD

Instructor of Psychiatry, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts; Psychiatrist, Wellcare Physicians Group, Norwood, Massachusetts

Emily Deans, MD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: Psychology Today

Robert L. Findling, MD
Robert L. Findling, MD

Professor, Department of Psychiatry, John Hopkins University; Director, Child & Adolescent Psychiatry, Johns Hopkins Hospital, Baltimore, Maryland

Robert L. Findling, MD, has disclosed the following relevant financial relationships:
Has received research support, acted as a consultant, or served on a speakers bureau for:
Alexza Pharmaceuticals; American Academy of Child & Adolescent Psychiatry; American Physician Institute; American Psychiatric Press; AstraZeneca; Bracket; Bristol-Myers Squibb; Clinsys; Cognition Group; Coronado Biosciences; Dana Foundation; Forest; GlaxoSmithKline; Guilford Press; John Hopkins University Press; Johnson & Johnson; KemPharm; Lilly; Lundbeck; Merck; National Institutes of Health; Novartis; Noven; Otsuka; Oxford University Press; Pfizer; Physicians Postgraduate Press; Rhodes Pharmaceuticals; Roche; Sage; Seaside Pharmaceuticals; Shire; Stanley Medical Research Institute; Sunovion; Supernus Pharmaceuticals; Transcept Pharmaceuticals; Validus; WebMD

Bradley Gaynes, MD, MPH
Bradley Gaynes, MD, MPH

Professor, Department of Psychiatry, Associate Chair of Research Training and Education, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Bradley Gaynes, MD, MPH, has disclosed no relevant financial relationships.

Joseph F. Goldberg, MD
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry, Icahn School of Medicine, Norwalk, Connecticut

Joseph F. Goldberg, MD, MS has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Otsuka Pharmaceutical Co., Ltd.; Sunovion; Supernus
Serve(d) as a speaker or member of a speakers bureau for: Merck & Co, Inc; Neurocrine Biosciences, Inc.; Sunovion; Takeda Pharmaceuticals North America, Inc.; Lundbeck, Inc.; Vanda Pharmaceuticals Inc.
Royalties from: American Psychiatric Publishing, Inc.

Eric Hollander, MD
Eric Hollander, MD

Professor of Psychiatry & Behavioral Sciences; Director, Autism and Obsessive-Compulsive Disorder Spectrum Program, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York

Eric Hollander, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: Shire; Sunovion
Received research grant from: Roche; Caremark

Scott H. Kollins, PhD
Scott H. Kollins, PhD

Professor and Vice-Chair for Research Strategy & Development, Department of Psychiatry and Behavioral Science, Duke University Medical Center, Durham, North Carolinaa

Scott H. Kollins, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Purdue Pharma L.P.; Akili Interactive Labs; Alcobra Ltd.; Jazz Pharmaceuticals, Inc.; Ironshore Pharmaceuticals & Development, Inc.; Sunovion Pharmaceuticals; Rhodes Pharmaceuticals L.P.; Shire; KemPharm, Inc.; NLS Pharma
Received research grant from: Purdue Pharma L.P.; Akili Interactive Labs; Alcobra Ltd.; Bose Corporation; Ironshore Pharmaceuticals & Development, Inc.; Aevi Genomic Medicine, Inc.; Sunovion Pharmaceuticals; Rhodes Pharmaceuticals L.P.; Shire; KemPharm, Inc.; NLS Pharma
Received income in an amount equal to or greater than $250 from: Purdue Pharma L.P.; Akili Interactive Labs; Alcobra Ltd.; Jazz Pharmaceuticals, Inc.; Ironshore Pharmaceuticals & Development, Inc.; Sunovion Pharmaceuticals; Rhodes Pharmaceuticals L.P.; Shire; SK Life Sciences, Inc.; KemPharm, Inc.; NLS Pharma

Jeffrey A. Lieberman, MD
Jeffrey A. Lieberman, MD

Chairman, Department of Psychiatry, Columbia University; Chairman and Psychiatrist-in-Chief, Department of Psychiatry, New York-Presbyterian Hospital/Columbia University Medical Center, New York, New York

Jeffrey A. Lieberman, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Clintara; Intracellular Therapies; Pierre Fabre
Received research grant from: Alkermes; Novartis/Vanda
Patent: Repligen

Jon McClellan, MD
Jon McClellan, MD

Professor, Department of Psychiatry, University of Washington, Seattle; Medical Director, Child Study and Treatment Center, Lakewood, Washington

Jon McClellan, MD, has disclosed the following relevant financial relationships:
Received grant from: National Institute of Mental Health

Drew Ramsey, MD
Drew Ramsey, MD

Assistant Clinical Professor, Department of Psychiatry, Columbia University, New York, New York

Drew Ramsey, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: InterContinental Hotels Group; National Kale Day 501(c)3
Received income in an amount equal to or greater than $250 from: Sharecare

Stephen M. Strakowski, MD
Michael E. Thase, MD

Professor of Psychiatry and Behavioral Neuroscience, Psychology, and Biomedical Engineering, University of Cincinnati College of Medicine; Senior Vice President, Strategy and Transformation, University of Cincinnati Health, Cincinnati, Ohio

Stephen M. Strakowski, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Sunovion (chair of Data and Safety Monitoring Board)